Note: In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AB02,R03BB06

CAS registry number (Chemical Abstracts Service)

0000596-51-0

Chemical Formula

C19-H28-Br-N-O3

Molecular Weight

398

Therapeutic Category

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)

Chemical Names

1,1-dimetyl-3-hydroxypyrrolidinium bromide α-cyclopentylmandelate (WHO)

3-(α-Cyclopentylmandeloyloxy)-1,1-dimetylpyrrolidinium bromide (BAN)

3-Hydroxy-1,1-dimetylpyrrolidinium bromide α-cyclopentylmandelate (USP)

Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimetyl-, bromide (USP)

Foreign Names

• Glycopyrronii bromidum (Latin)
• Glycopyrroniumbromid (German)
• Glycopyrronium (bromure de) (French)
• Bromuro de glicopirronio (Spanish)

Generic Names

• Glycopyrrolate (OS: USAN)
• Glycopyrronium (OS: DCF)
• Glycopyrronium Bromide (OS: BAN, JAN)
• AHR 504 (IS)
• NVA 237 (IS)
• UNII-V92SO9WP2I (IS)
• Glycopyrrolate (PH: USP 41)
• Glycopyrronii bromidum (PH: Ph. Eur. 9)
• Glycopyrronium (bromure de) (PH: Ph. Eur. 9)
• Glycopyrronium bromide (PH: Ph. Eur. 9)
• Glycopyrronium Bromide (PH: BP 2018)
• Glycopyrroniumbromid (PH: Ph. Eur. 9)

Brand Names

• Bevespi [+ Formoterol]
  AstraZeneca, United States
• Cuvposa
  Merz, United States
• Enurev
  Ferrer Internacional, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece
• Glyco-P
  Klab, Thailand
• Glycopyrodyn
  Excelsior, Taiwan
• Glycopyrrolate
  Amneal Pharmaceuticals, United States; Appco Pharma, United States; Aurolife, United States; Concordia, United Kingdom; Dr. Reddy's, United States; Hikma, United States; Leading Pharma, United States; Luitpold Pharmaceuticals, United States; Natco, United States; Nexgen, United States; Par Pharmaceutical, United States; Rising, United States; Santos Biotech, United States; Somerset, United States; Sun Pharma, United States; Vintage, United States
• Glycopyrrolate [veterinary use]
  Cronus Pharma, United States
• Glycopyrrolate Omega
  Omega Laboratories, Canada
• Glycopyrrolate Sandoz
  Sandoz, Canada
• Glycopyrronium Bromide
  Accord Healthcare, United Kingdom; Colonis Pharma, United Kingdom; Concordia, United Kingdom; LENIS, Slovenia; Martindale, United Kingdom; Sanolabor, Slovenia
• Glycopyrronium Bromide and Neostigmine [+ Neostigmine]
  Concordia, United Kingdom; Martindale, United Kingdom
• Glycopyrronium Bromide and Neostigmine Metilsulfate Max [+ Neostigmine]
  Max Health, New Zealand
• Glycopyrronium Bromide Colonis
  Colonis, Malta
• Glycopyrronium Bromide Macarthys
  MaCarthys, Malta
• Glycopyrronium Bromide Martindale
  Martindale Pharmaceuticals, Cyprus
• Glycopyrronium Bromide Max
  Max Health, New Zealand
• Glycopyrroniumbromid Accord 200 μg/ml
  Accord Healthcare, Austria
• Glycostigmin [+ Neostigmin]
  Takeda, Finland
• Glykopyrroniumbromid Accord
  Accord Healthcare, Sweden
• Hospira Glycopyrrolate
  Pfizer, Australia
• Panthero
  Farmanova, Turkey
• Riarify [+ Beclometasone, + Formoterol]
  Chiesi Farmaceutici, Netherlands
• Robinul
  Aspen, New Zealand; Aspen Pharmacare, Australia; Biosyn, Germany; Casper Pharma, United States; Concordia, United Kingdom; Eumedica, Belgium; Meda, Denmark; Meda, Norway; Meda, Sweden; Pharmacare, South Africa
• Robinul 0.2mg
  Chiesi Pharmaceuticals, Austria; Eumedica, Luxembourg
• Robinul Forte
  Casper Pharma, United States
• Robinul V [veterinary use]
  Vetoquinol, France
• Robinul-Neostigmine [+ Neostigmine]
  Eumedica, Belgium; Eumedica, Luxembourg; Meda, Denmark; Meda, Norway; Meda, Sweden; Sintetica, Switzerland
• Robinul-V [veterinary use]
  Zoetis, United States
• Seebri
  Beijing Novartis Pharma Co., Ltd., China; Novartis, Argentina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Ireland; Novartis, Japan; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis Europharm, Cyprus; Novartis Europharm, Romania; Novartis Europharm, Tunisia; Novartis Farmaceutica, Spain; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Sunovion, United States; Novartis Singapore, Singapore
• Seebri 44 Mikrogramm
  Novartis Pharma, Germany
• Seebri 44mcg
  Novartis, Hungary; Novartis, Luxembourg; Novartis Europharm, Austria
• Seebri 50mcg
  Novartis, Israel; Novartis, Oman; Novartis Pharma, Switzerland
• Seebri Breezehaler
  Novartis, Estonia; Novartis, Indonesia; Novartis Pharma, Peru
• Sialanar
  BCM, Estonia; Proveca, United Kingdom; Proveca, Lithuania; Proveca, Sweden
• Sibry
  Novartis Pharma, Russian Federation
• Tovanor
  Gebro, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece
• Trimbow [+ Formoterol, + Beclometasone]
  Chiesi, Belgium; Chiesi, Germany; Chiesi, Denmark; Chiesi, Estonia; Chiesi, United Kingdom; Chiesi, Norway; Chiesi, Romania; Chiesi, Slovakia; Chiesi Farmaceutici, Sweden; Chiesi Farmaceutici S.p.A., Greece; Chiesi Pharma, Finland; Chiesi Pharmaceuticals, Netherlands
• Trimbow 87μg/5μg/9μg [+ Formoterol, + Beclometasone]
  Chiesi Farmaceutici, Austria
• Trydonis [+ Beclomethasone, + Formoterol]
  Chiesi Pharmaceuticals, Netherlands
• Ultibro [+ Glycopyrronium Bromide]
  Novartis, Denmark
• Ultibro [+ Indacaterol]
  Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Greece; Novartis Europharm, Romania; Novartis Europharm, Slovenia; Novartis Europharm Limited, Latvia; Novartis Farmaceutica, Spain; Novartis Pharma, Peru; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Novartis Singapore, Singapore
• Ultibro 110/50 [+ Indacaterol]
  Novartis Pharmaceuticals, Australia
• Ultibro 110mcg/50mcg [+ Indacaterol]
  Novartis, Oman; Novartis Pharma, Switzerland
• Ultibro 85 µg/43 µg [+ Indacaterol]
  Novartis, Hungary; Novartis Europharm, Austria
• Ultibro 85 Mikrogramm/43 Mikrogramm [+ Indacaterol]
  Novartis Pharma, Germany
• Ulunar [+ Indacaterol]
  Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece; Rovi, Spain; Sanfer, Mexico; UCB Pharma, Germany
• Utibron [+ Indacaterol]
  Sunovion, United States
• Vagolate
  AHPL, India
• Xoterna [+ Indacaterol]
  Ferrer Internacional, Spain; Gador, Argentina; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece

Glossary

Further information on drug naming conventions: International Nonproprietary Names.